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Abstract
Background: The exposure to pollutants such as diesel exhaust particles (DEP) is associated with an
increased incidence of respiratory diseases. However, the mechanisms by which DEP have an effect on
human health are not completely understood. In addition to their action on macrophages and airway
epithelial cells, DEP also modulate the functions of dendritic cells (DC). These professional antigen-
presenting cells are able to discriminate unmodified self from non-self thanks to pattern recognition
receptors such as the Toll like Receptors (TLR) and Scavenger Receptors (SR). SR were originally
identified by their ability to bind and internalize modified lipoproteins and microorganisms but also
particles and TLR agonists. In this study, we assessed the implication of SR in the effects of DEP associated
or not with TLR agonists on monocyte-derived DC (MDDC). For this, we studied the regulation of CD36,
CXCL16, LOX-1, SR-A1 and SR-B1 expression on MDDC treated with DEP associated or not with TLR2,
3 and 4 ligands. Then, the capacity of SR ligands (dextran sulfate and maleylated-ovalbumin) to block the
effects of DEP on the function of lipopolysaccharide (LPS)-activated DC has been evaluated.
Results: Our data demonstrate that TLR2 agonists mainly augmented CXCL16, LOX-1 and SR-B1
expression whereas DEP alone had only a weak effect. Interestingly, DEP modulated the action of TLR2
and TLR4 ligands on the expression of LOX-1 and SR-B1. Pretreatment with the SR ligand maleylated-
ovalbumin but not dextran sulfate inhibited the endocytosis of DEP by MDDC. Moreover, this SR ligand
blocked the effect by DEP at low dose (1 μg/ml) on MDDC phenotype (a decrease of CD86 and HLA-DR
expression) and on the secretion of CXCL10, IL-12 and TNF-α. In contrast, the decrease of IL-12 and
CXCL10 secretion and the generation of oxygen metabolite induced by DEP at 10 μg/ml was not affected
by SR ligands
Conclusion: Our results show for the first time that the modulation of DC functions by DEP implicates
SR. TLR agonists upregulated SR expression in contrast to DEP. Interfering with the expression and/or the
function of SR might be one way to limit the impact of DEP on lung immune response.
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Background
Airway mucosa represents the first line of defence against
invading airborne pathogens and particulate matters. A
high level of airborne particulate matters within the
inspired air is associated with an increased incidence of
respiratory diseases like allergic asthma and rhinitis [1].
Among these pollutants, road traffic and particularly the
diesel cars represent a major source of particulate matters
in urban area. Exposure to diesel exhaust particles (DEP)
is associated with exacerbations of asthma, chronic
obstructive pulmonary disease and allergic rhinitis [2-4].
DEP exert immunoregulatory functions through their first
action on resident cells in the lung including macro-
phages, airway epithelial cells, and dendritic cells (DC).
DC has been shown as playing a key role in the control of
the lung immune response. These effects induced by DEP
are probably responsible for its adjuvant activity that pro-
motes pro-allergic sensitization to common environmen-
tal allergens [5], exacerbation of existing airway diseases
[6,7], and increased susceptibility to respiratory virus
infections like influenza [8] or RSV infections [9]. Regard-
ing the modulation of DC functions, DEP do not induce
their maturation but rather slightly modulate the response
to potent maturation agents such as lipopolysaccharide
(LPS), a ligand of Toll-Like Receptor (TLR)4 [10,11]. This
effect involves the generation of reactive oxygen species
(ROS) and the inhibition of NF-κB activation [12]. How-
ever, the early mechanisms by which DEP affect DC func-
tions are not completely understood.
Whereas alveolar macrophages mainly reside in the alve-
olar region of the lung, immature myeloid DC (mDC)
constitute a dense network in close proximity to airway
epithelial cells [13]. Due to their role in the lung immune
response, mDC are also determinant in the induction and
the control of allergic asthma [14]. DC are professional
antigen-presenting cells that are essential for initiating
adaptive immune responses. They develop from bone
marrow-derived CD34+ precursor cells that travel in the
bloodstream to secondary lymphoid tissues and mainly to
the airway and gut mucosa. At a steady state and after
exposure to danger signals, airway epithelial cells recruit
immature DC or their precursors to sample inhaled anti-
gens [15,16]. After antigen processing, maturing DC leave
their resident sites towards the thoracic lymph nodes,
where they efficiently prime naive T cells [17]. The T cell
polarizing signals delivered by DC which are defined by
the degree of cell maturation, determine the issue of the T
cell response and the potential development of effector or
suppressor T cells.
DC are able to discriminate unmodified self from non-self
and altered/modified self thanks to a large family of recep-
tors so called the pattern recognition receptors that
include signalling receptors (e.g. Toll like Receptors
(TLR)) and endocytic receptors including Scavenger
Receptors (SR) [18,19]. The type of receptor involved in
Ag capture will determine its processing and the issue of
Ag presentation. Signalling and endocytic receptors coop-
erate to finely tune the degree of DC maturation and, by
this way, to impact on T cell activation and polarization.
SR were originally identified by their ability to bind and
internalize modified lipoproteins [18]. SR not only bind
modified self such as oxidized LDL but also non self
(microbes). In addition to their role in atherosclerosis, SR
play critical roles in tissue homeostasis and innate immu-
nity, e.g. by inducing apoptotic cell clearance. Different
cell types express SR, such as endothelial cells, macro-
phages and DC. In comparison with macrophages, DC
express a specific profile of SR belonging to different
classes including SR-A1, MARCO (class A), SR-B1/CLA-1
and CD36 (class B), LOX-1 and CXCL-16 (also named SR-
PSOX) (class D and E, respectively) [20]. The SR LOX-1,
also known as OLR1 (oxidized low density lipoprotein
(lectin-like) receptor 1) has also a C-type lectin-like
domain (CTLD) of the type found in natural killer cell
receptors (NKRs). CXCL16 also possesses a functional
CXC chemokine domain active on T cells in addition to
the mucin-like domain involved in the SR function.
Although binding of DEP to alveolar macrophages was
not inhibited by polyanionic ligand of SR [21], some SR
such as MARCO are implicated in inert particle clearance
[22].
These data suggest the implication of SR in the modula-
tion of DC functions by DEP. Our aim is to demonstrate
the involvement of SR in this process and the relationship
with the activation by TLR ligands. Indeed TLR4 agonist is
frequently associated with airborne particles [23]. In this
work we first studied the effect of DEP on the SR expres-
sion in immature and mature DC, and second, the modu-
lation by SR ligands of DEP uptake and effect. This role
was evaluated in the context of an exposure to DEP alone
or in association with TLR4 ligand. Our data demonstrate
that DEP modulate the expression of some SR in imma-
ture and mature DC. Pretreatment with SR ligands allows
to block some effects of DEP on cytokine production and
costimulatory molecule expression by DC, at least in part
through the modulation of DEP uptake. Taken together,
our results show for the first time that the modulation of
DC functions by DEP implicates the mobilization of SR.
Results
Modulation of mRNA expression of the SR CD36, CXCL16, 
LOX-1, SR-A1 and SR-B1/CLA-1 by DEP and TLR ligands
We first determined whether DEP alone or in costimula-
tion with TLR2 (Pam3CSK4 (10 μg/ml)), -3 (Polyinos-
inic-polycytidylic acid (poly(I:C))) (10 μg/ml), -4Particle and Fibre Toxicology 2009, 6:9 http://www.particleandfibretoxicology.com/content/6/1/9
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(Lipopolysaccharide (LPS)) (1 μg/ml) ligands, modify the
SR CD36, CXCL16, LOX-1, SR-A1 and SR-B1 mRNA
expression in monocyte-derived DC (MDDC) using quan-
titative RT-PCR. Preliminary experiments showed that the
optimal time of mRNA expression were 1 and 3 h stimu-
lation (data not shown). DEP did not markedly increase
the mRNA level of SR although a weak effect on CD36 was
observed after 1 h stimulation (p < 0.05) (Fig 1A). The
TLR2 ligand significantly increased the mRNA level of
CXCL16 (p < 0.001) and SR-B1 (p < 0.001), after 1 h stim-
ulation, and LOX-1 after 1 and 3 h stimulation (Fig 1A
and 1B) (p < 0.05). TLR3 agonist slightly enhanced the
mRNA level of CD36 (p < 0.05) after 1 h stimulation.
TLR4 ligand significantly increased the mRNA expression
of CD36 after 1 h stimulation (p < 0.001), and LOX-1
after 3 h stimulation. Expression of SR-A1 mRNA was not
modulated by TLR agonists after 1 and 3 h stimulation in
DC (data not shown). However, at 8 h activation, the
TLR2 and TLR4 agonists significantly decreased its expres-
sion (p < 0.05, Fig 2A) whereas the poly(IC) had no activ-
ity.
Activation by DEP combined with TLR ligands resulted in
the inhibition of TLR2 ligand-induced SR-B1 expression
(p < 0.05), and TLR4 ligand-induced CD36 expression (p
< 0.05) after 1 h stimulation. In contrast, DEP enhanced
at 3 h the effect of TLR2 (p < 0.05) and TLR4 ligands on
LOX-1. Exposure to DEP did not affect the expression of
SR-A1 even in the presence of TLR agonists (data not
shown).
Taken together, the results showed that DEP alone had a
weak effect on SR expression in comparison with that of
the TLR ligands. However, DEP modulated some of the
stimulatory properties of TLR agonists.
Modulation of protein expression for the CD36, CXCL16, 
LOX-1, SR-A1 and SR-B1/CLA-1 by DEP and TLR ligands
We next determined by flow cytometry the effect of these
stimuli on SR membrane expression in MDDC activated
during 6 and 24 h. At the opposite of the mRNA expres-
sion, DEP alone significantly decreased after 6 h stimula-
tion the expression of CD36 (p < 0.05) and SR-B1 (p =
NS) whereas it did not affect the level of CXCL16 and
LOX-1 (Fig 3A and 3C). TLR2 ligand significantly
increased the expression of LOX-1 after 6 h stimulation (p
< 0.05) and CXCL16 and SR-B1 after 24 h stimulation (p
< 0.05) whereas it significantly decreased the expression
of CD36 after 24 h stimulation (p < 0.05) (Fig 3A–D). The
activation by TLR3 agonist only tended to increase
DEP and PAMP modulate mRNA expression of Scavenger Receptors in MDDC Figure 1
DEP and PAMP modulate mRNA expression of Scavenger Receptors in MDDC. MDDC were maintained in 
medium alone or activated with TLR2, -3 and -4 ligands (Pam3CSK4 (10 μg/ml), poly(I:C) (10 μg/ml) and LPS (1 μg/ml) respec-
tively), associated or not with DEP (10 μg/ml) during 1 h (part A) and 3 h (part B). MDDC were harvested for mRNA isolation 
followed by measurement of CD36, CXCL16, LOX-1 and SR-B1 levels by quantitative RT-PCR. Results were expressed as the 
relative gene expression calculated for each experiment in folds (2-(ΔΔCt)) compared to unstimulated cells used as calibrator. 
Data reported the mean ± SEM from 4 independent experiments. +: p < 0.05; ++: p < 0.01; +++: p < 0.001 compared with cells 
in medium alone. ✻: p < 0,05 compared with TLR-treated cells.
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CXCL16 expression after 24 h. The TLR4 ligand increased
LOX-1 after 24 h stimulation, whereas it significantly
decreased the expression of CD36 after 24 h stimulation
(p < 0.05). The effect of TLR2 agonist was illustrated in fig-
ure 3C–D by histograms of flow cytometry from a repre-
sentative experiment. In contrast with the effect of LPS
and poly(IC), the TLR2 agonist significantly decreased the
expression of SR-A1 after 24 h activation (Fig 2B) but not
after 6 h (data not shown).
Associated with TLR ligands, DEP decreased the effect of
the TLR2 ligand on SR-B1 expression after 24 h stimula-
tion (Fig 3B and 3D), but increased the action of the TLR4
ligand after 6 h stimulation (p < 0.05) (Fig 3B). Moreover,
DEP significantly enhanced the action of TLR2 ligand on
LOX-1 expression at 6 h stimulation (p < 0.05).
Since SR had a rapid turnover, we have evaluated the total
expression of SR in DC after 6 and 24 h incubation by
immunofluorescence on permeabilized cells. Whereas no
modulation was detected at 6 h, activation for 24 h by
TLR2 and TLR4 ligands significantly inhibited (33% and
39% decrease, respectively) the intracellular labeling of
anti-CD36 antibody as reported for TLR2 in the fig 4. DEP
partially reversed the effect of TLR2 agonist whereas the
particles alone did not modulate CD36 expression. No
modulation was observed for SR-B1 and LOX-1. Concern-
ing CXCL16, activation by TLR2 agonist increased the
intracellular expression of this SR as detected on the mem-
brane (22% increase, p < 0.05). In contrast, addition of
DEP did not affect its expression.
Taken together, the results showed that, as reported for
mRNA expression, activation by TLR ligands modulate SR
membrane expression in different ways. DEP alone tend
to decrease the expression of CD36 and SR-B1. Moreover,
DEP modulated the effect of TLR2 and TLR4 ligands on
the level of LOX-1 and SR-B1.
Modulation by DEP of LPS-induced MDDC maturation: 
effect of SR ligands
Since DEP modulated the expression of HLA-DR, CD83
and CD86 in LPS-stimulated MDDC [10], we studied the
capacity of poly-specific SR ligands (maleylated ovalbu-
min and dextran sulfate) to reverse the action of DEP on
MDDC maturation.
As previously described, the effect of DEP was different
according to the protocol (preincubation with DEP versus
co-incubation with DEP and LPS) (Fig 5). DEP at the dose
of 1 μg/ml significantly inhibited the LPS-induced upreg-
ulation of CD86 and HLA-DR (p < 0.05) when the ligands
were added simultaneously. Addition of dextran sulfate
and maleylated-ovalbumin blocked the inhibitory effect
of DEP on LPS-stimulated DC (p < 0.05). In contrast,
TLR2 activation modulates protein expression of SR-A1 in  MDDC Figure 2
TLR2 activation modulates protein expression of SR-
A1 in MDDC. MDDC were cultivated with TLR2, -3 and -4 
ligands respectively Pam3CSK4 (10 μg/ml), poly(I:C) (10 μg/
ml) and LPS (1 μg/ml) during 8 h for the mRNA expression 
(part A) and 24 h for the protein membrane expression (part 
B). A- MDDC were harvested for mRNA isolation followed 
by measurement of SR-A1 mRNA levels by quantitative RT-
PCR. Results were expressed as the mean ± SEM of the rela-
tive gene expression calculated for each experiment in folds 
(2-(ΔΔCt)) compared to unstimulated cells used as calibrator (n 
= 5). B- Dendritic cells were labeled for SR-A1, and analyzed 
by flow cytometry. Data are expressed as the mean ± SEM 
from 5 independent experiments. *: p < 0.05; **: p < 0.01 
compared with cells in medium alone.
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DEP and PAMP modulate protein expression of Scavenger Receptors in MDDC Figure 3
DEP and PAMP modulate protein expression of Scavenger Receptors in MDDC. MDDC were cultivated with 
TLR2, -3 and -4 ligands respectively Pam3CSK4 (10 μg/ml), poly(I:C) (10 μg/ml) and LPS (1 μg/ml), associated or not with DEP 
(10 μg/ml). A-B Dendritic cells activated during 6 h (A) and 24 h (B) were labelled for CD36, CXCL16, LOX-1 and SR-B1, and 
analyzed by flow cytometry. Data are expressed as the mean ± SEM from 3 to 7 independent experiments. +: p < 0.05; ++: p < 
0.01 compared with unstimulated cells. ✻: p < 0,05 compared with TLR-treated cells. C-D Flow cytometry histograms of a rep-
resentative experiment. MDDC were cultivated for 6 h (C) and 24 h (D) with DEP (blue line), with TLR2 ligand (Pam3CSK4, 
red line), and with both stimuli (green line) as compared with cells in medium alone (black line).
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these SR ligands did not modulate the action of LPS alone
on the 3 markers of maturation.
Preincubation with DEP at 1 μg/ml had a weak inhibitory
effect on LPS-induced CD83 expression in comparison to
LPS alone, whereas HLA-DR and CD86 were not modi-
fied. Addition of maleylated-ovalbumin reversed the
action of DEP on CD83 expression. Whereas DC-SIGN
expression was not affected by DEP treatment, these parti-
cles have an additive effect on the LPS-induced decrease of
the Mannose Receptor expression (data not shown). Addi-
tion of SR ligands did not antagonize this activity (data
not shown).
Taken together, these data confirmed that DEP modified
the phenotype of LPS-induced matured MDDC, whereas
SR ligands blocked the effects of DEP.
Modulation by DEP of LPS-induced cytokine and 
chemokine production by MDDC: effect of SR ligands
The involvement of SR in the effect of DEP on LPS-
induced cytokine and chemokine secretion by MDDC was
also studied. Activation by LPS alone increased the pro-
duction of CXCL10/IP-10, IL-6, IL-10, IL-12p70 and TNF-
α (Fig 6) whereas DEP alone had no effect (data not
shown). Dextran sulfate (but not maleylated ovalbumin)
strongly inhibited the LPS-induced production of IL-10
whereas addition of SR ligands did not significantly mod-
ulate the other cytokines.
Preincubation with low dose (1 μg/ml) of DEP signifi-
cantly increased the LPS-induced production of CXCL10/
IP-10, TNF-α, IL-6 and IL-12p70 (p < 0.05). Maleylated-
ovalbumin strongly inhibited the production of CXCL10/
IP-10 (p < 0.001), IL-12 (p < 0.05) and TNF-α (p < 0.05)
induced by low dose of DEP, whereas dextran sulfate had
no significant activity. Surprisingly, IL-6 secretion was not
modified by treatment with SR ligands. Preincubation
with high dose of DEP did not have any significant effect.
Coincubation with low dose of DEP significantly
increased CXCL10 production induced by LPS (p < 0.05),
a modulation which is antagonized by treatment with
both SR ligands, dextran sulfate (p < 0.05) and maleylated
ovalbumin (p < 0.001). In contrast, simultaneous addi-
tion of LPS and the highest dose (10 μg/ml) of DEP inhib-
ited the production of CXCL10 and IL-12 in comparison
with LPS alone. Nevertheless, the addition of SR ligands
did not neutralize this effect. Preincubation and simulta-
neous treatment with DEP with and without maleylated-
ovalbumin had any effect on IL-10 synthesis (Fig 6).
Taken together, these data showed that low dose of DEP
increased the synthesis of cytokines by LPS-stimulated
DC, whereas the exposure to high dose was able to inhibit
CXCL10 and IL-12 production. Preincubation with
maleylated-ovalbumin mainly blocked the effect of low
dose of DEP but did not antagonize the activity of the high
dose.
DEP and TLR2 agonist modulate the total protein expression of CD36 and CXCL16 in MDDC Figure 4
DEP and TLR2 agonist modulate the total protein expression of CD36 and CXCL16 in MDDC. MDDC were cul-
tivated during 24 h with DEP (blue line), with TLR2 ligand (Pam3CSK4, red line), and with both stimuli (green line) as compared 
with cells in medium alone (black line). Dendritic cells were labelled after cell permeabilization for CD36, CXCL16, LOX-1, 
SR-B1 and with an isotype control (dotted line) and then, analyzed by flow cytometry.
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Effect of DEP on DEP endocytosis and ROS production by 
DC
In order to elucidate the action mechanism of SR ligands,
endocytosis of DEP by MDDC has been evaluated. The
uptake of particles induced an increase in the granularity
of the cells, which led to a greater scattering of the laser
light in flow cytometry [24]. This is confirmed by our data
reported in figure 7 showing that exposure to DEP slightly
but significantly (p < 0.05) increased side scatter (SC) in
DC. Preincubation with maleylated-ovalbumin but not
with dextran sulfate dose dependently inhibited the
uptake of DEP (p < 0.05).
Since exposure to DEP secondarily induced generation of
ROS involved in the modulation of DC functions [12],
production of these metabolites by MDDC has been eval-
uated. At steady state, MDDC produced low level of ROS,
as measured by flow cytometry. Activation of PMA signif-
icantly increased the generation of ROS which reached its
maximum at 2 h (p < 0.05). DEP significantly increased
ROS production after 4 h stimulation (p < 0.05), whereas
this treatment had a weak effect at 2 h (fig 8A). On the left
histogram, treatment with DEP (bold line) induced a
strong gap at 4 h (about 40% of the ΔMFI obtained with
PMA).
We also analyzed the capacity of maleylated-ovalbumin
to modulate the DEP-induced ROS generation (Fig 8B).
Maleylated-ovalbumin had no significant effect on DEP-
induced ROS production observed after 4 h stimulation.
Discussion
There is growing evidence that inhaled particulate matter
derived from diesel contributes to the increased incidence
of allergic diseases, respiratory infections and mortality
[1,5-7,9]. The effect of DEP on lung immune response
probably implicated the modulation of pulmonary DC
functions.
In this study, we assessed whether DEP may affect the
expression and the function of SR and by this way, can
modulate the function of DC during activation by TLR lig-
ands. Indeed, TLR ligands are frequently associated with
airborne particles [23]. Here we showed that DEP modu-
late the activity of TLR ligands on SR expression in DC.
Moreover, pretreatment with SR ligands blocks some
effects of DEP on LPS-induced DC maturation and
cytokine production through a still unknown mechanism.
Within airway mucosa, particulate matter-exposed bron-
chial epithelial cells secrete the DC chemoattractant
CCL20/MIP-3α, CCL2/MCP-1, and CCL5/RANTES [25].
Therefore, one might expect that DC would be among the
first cells to interact with inhaled particulate matter. In the
current study, we used well-established protocols that are
thought to yield immature MDDC representative of those
present in vivo at mucosal sites [26]. Since respiratory tract
DC are rapidly derived from circulating precursors
[27,28], we believe our experiments provide a reasonable
approximation of how DC and DEP interact in vivo. In
addition, DC can insert dendrites between airway epithe-
lial cells to directly capture the particle or microorganism
within the airway lumen [29].
DEP modulate LPS-induced MDDC maturation: effect of SR  ligands Figure 5
DEP modulate LPS-induced MDDC maturation: 
effect of SR ligands. MDDC were preincubated 2 h with 
20 μg/ml dextran sulfate, 100 μg/ml maleylated ovalbumin 
associated or not with 1 or 10 μg/ml DEP and then, 100 ng/
ml LPS were added (Preincubation). For the coincubation, 
the three ligands are added simultaneously. After 24 h incu-
bation, MDDC were labeled for HLA-DR, CD83 and CD86 
and were analyzed by flow cytometry. Data are expressed as 
the mean ± SEM from 7 independent experiments. ✻: p < 
0.05 compared with LPS-treated cells. +: p < 0.05 compared 
with the condition without SR ligand.
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Modulation of SR expression
There are few studies about the regulation of the expres-
sion of SR on DC. Concerning the regulation of class-A SR
in DC, Amiel et al showed that SR-A expression is upregu-
lated during DC maturation, and is correlated with the
expression of the murine DC marker CD11c [30]. Another
study showed that advanced glycosylation end (AGE)-BSA
upregulated SR-A expression on DC via MAP kinases path-
way (Jnk) [31]. The last work showed the upregulation of
SR-B1 during the differentiation of MDDC. SR-B1 expres-
sion was suppressed by LPS, IFN-γ and TNF-α in mono-
cytes and macrophages [32]. In the same way, we detect a
transient decrease of SR-B1 expression in LPS-stimulated
MDDC. We have also evaluated on MDDC the protein
expression of MARCO, a SR involved in the particle clear-
ance within the lung. Using a mAb (PLK1 clone; HBT,
Uden, The Nederlands), our data revealed that this SR is
nearly undetectable on MDDC by flow cytometry after
intracellular and extracellular labeling, whatever the con-
dition of stimulation (data not shown).
In this study, the selection of the five SR is based on their
expression in airway mucosa particularly in airway epithe-
lium and in MDDC (data not shown). In addition, these
receptors are known to be implicated in the modulation
of TLR activity [33-36]. Our results showed that DEP had
a weak effect on the SR mRNA expression, in contrast with
the strong effect induced by TLR2 and TLR4 ligands. How-
ever, DEP alone seems to decrease the protein expression
of CD36 and SR-B1 suggesting their mobilization during
their interaction with DEP. In contrast, TLR2 ligand and at
a lower level, TLR4 agonist enhances both the mRNA and
protein expression of LOX-1, CXCL16 and SR-B1. Con-
cerning SR-A1 and CD36, there is a clear dissociation
between the TLR-dependent modulation of mRNA
(increased) and protein (decreased) expression suggesting
DEP modulate LPS-induced cytokine and chemokine production by MDDC: effect of SR ligands Figure 6
DEP modulate LPS-induced cytokine and chemokine production by MDDC: effect of SR ligands. MDDC were 
preincubated 2 h with 20 μg/ml dextran sulfate, 100 μg/ml maleylated ovalbumin associated or not with 1 or 10 μg/ml DEP and 
then, 100 ng/ml LPS were added (Preincubation). For the coincubation, the three ligands are added simultaneously. After 24 h 
incubation, the concentrations of IP-10, IL-12, IL-6 and TNF-α were measured by ELISA. Data are expressed as the mean ± 
SEM from 8 independent experiments. ✻: p < 0.05 compared with LPS-treated cells. +: p < 0.05; ++: p < 0.01 compared with 
the condition without SR ligand.
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that their membrane expression in DC are mainly control-
led by post-transcriptional mechanisms as previously
reported [20]. Measurement of intracellular expression
revealed that the level of CD36 and CXCL16 is parallel in
both extracellular and intracellular compartment whereas
this is not true for LOX-1 and SR-B1. According to these
data, the mechanisms controlling the membrane expres-
sion of LOX-1 and SR-B1 are probably very different from
those of CD36 and CXCL16. Since TLR3 activation had a
weak effect on SR level in contrast to TLR2 and TLR4, we
can suspect that MyD88-dependent pathway mobilized
by both TLR is involved in the modulation of SR expres-
sion. Associated with pathogen-associated molecular pat-
tern (PAMP), DEP modulate the activity of TLR2 and TLR4
ligands according to the SR. As previously reported [10-
12], DEP can modulate the signalling pathways activated
by TLR and by this way, controlled the modulation of SR
expression. In addition, we can suspect that DEP uptake
by MDDC directly mobilizes some SR such as CD36 and
SR-B1 and interferes with the activity of TLR agonists on
SR expression.
Regulation of DC maturation induced by TLR ligand
There are some controversial data in the literature con-
cerning the impact of DEP exposure on DC maturation.
Most studies show that DEP alone have no effect on DC
maturation whereas it can act as an adjuvant in order to
increase the response to an allergen or a TLR ligand [10].
In contrast, DEP can also inhibit some signals induced by
TLR activation and deviate the phenotype of mature DC
towards a pro-Th2 type. Indeed, DEP inhibit IL-12 mRNA
and protein expression in DC, and decrease IFN-γ produc-
tion by T lymphocytes cocultured with DEP-exposed DC
[11]. DEP in mice inhibited DC maturation (IL-12 pro-
duction and co-stimulatory molecule expression) induced
by TLR2, 3, 4 and 9 ligands [12]. Finally, another report
also suggests that direct exposure to airborne particulate
matter from diesel vehicles increased the expression of
MHC class II and costimulatory molecules and the pro-
duction of TNF-α, IL-12p40, IL-6, and VEGF [2].
In our model, DEP alone have no effect on DC matura-
tion, suggesting that their effect on MDDC is dependent
upon their origin and their preparation (addition of sur-
face activator or surfactant) as previously reported [37]. In
our hands, DEP modulate the LPS-induced DC matura-
tion according to the timing and to the dose. We show
that the low dose of DEP increases the synthesis of
cytokine by LPS-stimulated DC, whereas the high dose
blocks IP-10 and IL-12 production. Moreover, SR ligands
are able to reverse some effects of DEP. One hypothesis to
explain these data might be that there is a competition for
the uptake and internalization of DEP. Our results dem-
onstrated that mOva but not dextran sulfate inhibited in
a dose-dependent manner the uptake of DEP. This sug-
gests that it is not the only mechanism involved in the
activity of poly-specific SR ligands. The fact that SR ago-
nists only block the action of low dose of DEP, can be
explained by an insufficient molecular ratio between SR
ligands and DEP in order to inhibit the effect of the high
dose. Another explanation might be that, according to the
dose, different receptors are implicated in the DEP effect.
This hypothesis is likely since both doses of DEP have an
opposite effect on cytokine secretion by DC. The implica-
tion of the xenobiotic sensor AhR has been previously
mentioned [38]. Moreover, SR are also described as core-
ceptors for TLR, DEP can interfere with TLR-induced sig-
nalling through the mobilization of SR. For example,
activation with the TLR2 ligand Kp-OmpA is dependent of
both SREC-1 and LOX-1 or with diacylglycerides, of CD36
[34,39]. CD36, with established roles in recognition of
endogenous and exogenous ligands, facilitates TLR2 sign-
aling [40]. In addition, CXCL16 is involved in TLR9 acti-
vation by plasmacytoid DC [33]. Preincubation with
maleylated-ovalbumin mainly block all the effects of low
dose of DEP whereas dextran sulfate have a more
restricted effect. Maleylated OVA binds to most of the SR,
SR ligands modulate DEP endocytosis Figure 7
SR ligands modulate DEP endocytosis. MDDC were 
preincubated for 15 min with 20 and 100 μg/ml dextran sul-
fate or maleylated ovalbumin and then, DEP (10 μg/ml) was 
added. After 6 h incubation, side scatter (SSC) of MDDC was 
analyzed by flow cytometry. Data are expressed as the differ-
ence between the SSC in DEP-stimulated and inactivated 
cells. The data reported the mean ± SEM from 5 independent 
experiments. ✻: p < 0.05 compared with cells with DEP 
alone (medium).
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including the class II scavenger receptors SR-AI/II, SR-BI
and CD36 [20]. Moreover, we have observed that CHO
cells expressing either CXCL16, LOX-1 or SREC-1 strongly
bind FITC-conjugated maleylated OVA (data not shown).
Dextran sulfate has been reported to inhibit the binding
of several ligands to SR-AI/II, SREC-I, CXCL16 and LOX-1
[41] whereas this ligand does not interact with CD36 [42].
Moreover, sulfated glyconconjugates, including dextran
sulfate, share a binding inhibition pattern consistent with
class A or C activity [43]. According to our data, we can
suspect that class B SR (SR-B1, CD36) are presumably
involved within DEP effect in DC. To confirm the impli-
cation of SR, it would be interesting to test other inhibi-
tory methods like gene silencing.
The modulation of IL-12 and CXCL10 production (two
major cytokines involved in the differentiation and the
recruitment of Th1 cells) by SR ligands may have a strong
impact on the capacity of DEP-exposed DC to polarize the
T cell response. Since this effect is only observed at low
doses, we can suspect that it is mainly involved in the long
term effect of chronic exposure to these particles.
DEP effect on DC phenotype
Our data demonstrate that coincubation with LPS and
DEP affects the phenotype of mature DC, decreasing the
expression of the costimulatory molecule CD86 and of
the HLA-DR molecule. We demonstrate that this effect is
dependent on SR mobilization. This process could impact
the T cell response and polarization since CD86 is known
to be implicated in Th2 cell development.
Recently, Porter et al demonstrate that airborne particulate
matter from diesel vehicles enhanced the MR expression
Effect of DEP on ROS production by MDDC Figure 8
Effect of DEP on ROS production by MDDC. A. MDDC were incubated in medium alone, with DEP (10 μg/ml) or with 
PMA (100 ng/ml) for different time periods. ROS production was analyzed by flow cytometry. The left histogram reported the 
mean ± SEM from 6 independent experiments whereas the flow cytometry histograms show the data obtained in one repre-
sentative experiment. +: p < 0.05 compared with cells in medium alone. B. Modulation by maleylated ovalbumin of DEP effect 
on MDDC activated for 2 and 4 h. Data in the left histogram are expressed as the mean ± SEM from 6 independent experi-
ments. The flow cytometry histograms reported the data obtained in one representative experiment. +: p < 0.05 compared 
with cells in medium alone.
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and potentialized antigen uptake (dextran-FITC) whereas
LPS decreased both MR expression and antigen uptake
[2]. In the present study, DEP alone had no effect on MR
expression (data not shown) whereas it had an additive
effect on the LPS-induced decrease of this receptor. As
underlined above, this discrepancy is probably related to
different origins of the particles.
ROS production
It has been demonstrated in human and murine models
that the effects of DEP on DC are associated with ROS pro-
duction [11,12]. Notably, DEP-induced ROS production
triggers the activation of a signaling pathway mediated by
nuclear factor-erythroid 2 (NF-E2)-related factor 2 that
suppresses IL-12 production [12]. In our model, the inhi-
bition of IL-12 production as well as ROS production are
only detected at high concentrations of DEP and both
seem to be independent of SR mobilization. These data
strongly suggest that the activation of NF-E2 in not
dependent of SR-induced signalling pathways. At the
opposite, SR seems to be involved in the upregulation of
the cytokine production triggered by the low dose of DEP.
Conclusion
Taken together, our results show that the modulation of
DC functions by DEP involves the mobilization of SR.
Moreover, the impact on DC functions appears to be dif-
ferent according to the dose and probably implicates dif-
ferent signalling pathways. Interfering with the expression
and/or the function of SR might be one way to limit the
impact of DEP on lung immune response and on the
induction and the exacerbation of lung diseases.
Methods
Preparation of DEP
We used standard DEP (standard reference material
(SRM) 2975) obtained from the National Institute for
Standards and Technology (NIST, Gaithersburg, USA).
The material was collected from a filtering system
designed specifically for diesel-powered forklifts. Its
chemical composition is mentioned in the Certificate of
Analysis from NIST. DEP were diluted in a solution con-
tainig 0,04% Dipalmitoyl Phosphatidylcholin (Fluka
Chemie, Buchs, Switzerland). To minimize aggregation,
DEP were sonicated for 15 minutes and shaked prior to
their dilution. The suspension was diluted in culture
medium to the final concentrations required for exposure
of the cells.
Preparation of MDDC and DEP exposure
Blood monocytes from healthy volunteers were purified
by positive selection over a MACS column using anti-
CD14-monoclonal antibodies (mAb) conjugated
microbeads (Miltenyi Biotec GmBH, Bergisch Gladbach,
Germany) and were differentiated into dendritic cells by
standard procedures [26]. Briefly, monocytes were culti-
vated at 1 × 106 cells/ml for 5 days in RPMI 1640 supple-
mented with 10% heat-inactivated FCS (Invitrogen,
Paisley, UK) containing 10 ng/ml IL-4 and 25 ng/ml GM-
CSF (PromoCell, Heidelberg, Germany).
At day 5, CD14-CD11c+HLA-DRlow immature monocyte-
derived DC were obtained as characterized by their phe-
notype and the low level of cytokine production (data not
shown).
Cells were either left untreated or were exposed for 1, 3, 6,
8 or 24 h to DEP (10 μg/ml) with or without the TLR2 lig-
and Pam3CSK4 (10 μg/ml), the TLR3 ligand poly(I:C) (10
μg/ml) or the TLR4 ligand LPS (1 μg/ml) (Invivogen, San
Diego, CA) depending on the experiments. The vehicle for
DEP containing 0.04% dipalmitoyl phosphatidylcholin
was added in the control wells.
To evaluate their maturation in the presence of DEP, the
activation protocol was as follows: MDDC were preincu-
bated with the SR ligands Dextran sulfate (20 μg/ml) or
maleylated- and deglycosylated ovalbumin (100 μg/ml)
with or without DEP (1 or 10 μg/ml) during 2 h before
addition of LPS (100 ng/ml) for 24 h. In some experi-
ments, the SR ligands, DEP and LPS were added at the
same time. The preparation of SR ligands are endotoxin-
free, as measured by the limulus amebocyte assay (Lonza,
Verviers, Belgium). As previously described, dextran sul-
fate particularly targets SREC-1 and CXCL16 whereas
maleylated-ovalbumin binds to most of the SR [44-46].
Cell viability was evaluated in each condition of activa-
tion by trypan blue exclusion after 24 h incubation and no
significant decrease was detected in the presence of each
activator or their combination.
Real Time quantitative PCR
Total RNA was isolated from DC exposed to DEP and/or
to TLR ligands. After 1 or 3 h incubation, cells were
washed in sterile cold PBS, lysated by using TRIzol reagent
(Invitrogen) and RNA were isolated according to manu-
facturer's instructions. RNA concentration was deter-
mined by spectrophotometry and its quality was
evaluated by electrophoresis through a 0.8% agarose gel
visualized using Gelstar staining. Retro-transcription and
Real-Time quantitative PCR were performed using Super-
Script™ Platinum® SYBR® Green Two-Step qRT-PCR Kit
with ROX (Invitrogen, Paisley, Scotland) according to
manufacturer's instructions. Forty-five cycles of cDNA
amplification were performed at 55°C (30s) after hybri-
dation at 60°C (20s). In order to obtain a normalized tar-
get value, the house-keeping gene actin was used. Forward
and reverse primers for CD36, CXCL16, Lox-1 and SR-B1
were designed as follows: CD36 (forward 5'-TGTC-
CGCGAAGAAGGTACAA, reverse 5'-TCACTTCCTGT-Particle and Fibre Toxicology 2009, 6:9 http://www.particleandfibretoxicology.com/content/6/1/9
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GGATTTTGCAC); CXCL16 (forward 5'-
GGCTTTGGACCCTTGTCTCTTG, reverse 5'-TTGCGCT-
CAAAGCAGTCCACT); LOX-1 (forward 5'-AGT-
GGACACAATTACGCCAGGT, reverse 5'-
ATCTGCCCTTCCAGGATACGA); SR-A1 (forward 5'-
TTCAAAGCTGCACTGATTGCC, reverse 5'-TTCTTCGTT-
TCCCACTTCAGGA); SR-B1 (forward 5'-TGACGATCCCT-
TCGTGCATT, reverse 5'-CATCCCAACAAACAGGCCAA);
actin (forward 5'-TCCTCACCCTGAAGTACCCCA, reverse
5'-AGCCACACGCAGCTCATTGT).
Results were expressed mean +/- SEM of the relative gene
expression calculated for each experiment in folds (2-
(ΔΔCt)) compared to unstimulated cells used as calibrator.
Chemokine and cytokine measurements
The concentrations of cytokines and chemokines in the
culture supernatants were determined by sandwich
enzyme immunoassay as described by the manufacturer,
R&D systems for CXCL10/IP-10, IL-6, and TNF-α or Dia-
clone (Besançon, France) for IL-12p70.
Flow cytometry
After the recovery of MDDC supernatants, cells were incu-
bated with PBS/EDTA (2 mM) and were detached by
scraping. MDDC were centrifuged and resuspended in
PBS containing 2% FCS. Cells were labeled (30 min, 4°C)
with murine FITC-conjugated anti HLA-DR and DC-SIGN
mAb, PE-conjugated anti CD80, CD83 and Mannose
Receptor mAb, APC-conjugated anti CD86 and CD11c
mAb or mouse IgG isotype controls conjugated with FITC,
PE or APC (BD Pharmingen, except for CD83 from Beck-
man Coulter). Cells were washed with cold PBS and fixed
with 1% paraformaldehyde in PBS.
To study SR expression, cells were labelled (30 min, 4°C)
with mouse anti-LOX-1 (HBt), -SR-B1 (BD) and -CD36
(Labvision), goat anti-CXCL16 (R&D systems) antibodies
or the relevant isotype control. Binding of unlabelled Ab
or isotype control was detected by addition of FITC-con-
jugated anti-mouse or PE-conjugated anti-goat IgG anti-
bodies (Invitrogen). In some experiments, the procedure
was reproduced with cells previously fixed and permeabi-
lized according to the procedure of the kit manufacturer
(BD Biosciences). For SR-A1, cells were directly labelled
with an FITC-conjugated anti-SR-A1 monoclonal anti-
body (R&D Systems). Then, cells were washed, fixed with
paraformaldehyde in PBS and 10000 events were ana-
lyzed on a FACScalibur flow cytometer with CellQuest
software (Becton Dickinson). Results are expressed as the
difference between median fluorescence intensity (MFI)
with specific antibody minus the isotype control MFI
(ΔMFI).
Analysis of oxidative metabolism
10 μM of H2DCFDA (Dihydro-DichloroFluorescein Dia-
cetate) was added to 2 × 105 DC cultured in PBS for 30
minutes before stimulation with DEP (10 μg/ml) associ-
ated or not with SR ligand maleylated-ovalbumine, posi-
tive control PMA (100 ng/ml) for 2 and 4 h. ROS
generation was quantified by Flow Cytometry. Results are
expressed as the difference between median fluorescence
intensity (MFI) with DCFDA minus the autofluorescence
control MFI (ΔMFI).
Statistical analysis
Results are expressed as the mean ± SEM. The statistical
significance of the differences between experimental
groups was calculated by ANOVA1 with a Bonferroni post
test (GraphPad Prism 4 Software, San Diego, USA).
Results with a P value of less than 0.05 were considered
significant.
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